ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1038

Macrophage-Fibroblast Crosstalk Pathways Amplify RA Joint Pathology

Laura T. Donlin1, Jennifer Ding1 and Lionel B. Ivashkiv1,2, 1Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 2Weill Cornell Graduate School of Medical Sciences, New York, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Fibroblasts, inflammation and macrophages, Synovial Immune Biology

  • Tweet
  • Email
  • Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Macrophages and synovial fibroblasts represent key cellular drivers of RA. The goal of this study was to define how the complex cellular programs of macrophages and fibroblasts crossregulate within an inflammatory setting and potentially perpetuate pathologic responses. Previously, we have shown that soluble synovial fibroblast products suppress the macrophage TNF-induced Type I Interferon response. Here through a next-gen sequencing transcriptome analysis, we describe on a global scale how the macrophage TNF-a response is reshaped by synovial fibroblast factors, ultimately converting classic anti-inflammatory/resolution pathways into programs that feedback to support fibroblast growth and function. Furthermore, macrophages isolated directly from RA synovium indeed activate a subset of these gene expression networks, suggesting these macrophage-fibroblast crosstalk pathways represent novel therapeutic targets.

Methods

Human blood derived macrophages and human RA synovial fibroblasts were co-cultured in transwell plates and treated with TNF for 2 days. The transcriptomes of both cell types were analyzed by RNA sequencing (RNAseq). Pathway analysis programs identified macrophage responses specifically controlled by synovial fibroblasts, as well as identified candidate soluble crosstalk mediators. Cellular STAT3 activity was monitored by Western blot detection of phospho-STAT3 levels and by qPCR analysis of STAT3-dependent genes, while the soluble mediators responsible for inducing differential STAT3 responses were confirmed with neutralizing antibodies in the culture media.

 

Results

Synovial fibroblasts modified specific programs within the macrophage inflammatory response, impacting 30% of TNF-regulated genes. Pathway analysis demonstrated fibroblast factors largely transformed macrophage lipid programs and induced growth factor responses, including genes known to promote wound healing activities and growth of fibroblasts. Interestingly, while TNF-a alone induced an anti-inflammatory STAT3 response, TNF-a combined with fibroblast factors blocked this resolution response and instead diverted STAT3 activity towards mitogenic and metabolic pathways. Furthermore, initial analysis of synovial macrophages isolated directly from RA synovium revealed a subset of the crosstalk pathways identified in the in co-culture system including specific growth factor responses.

Conclusion

We propose the combination of inflammatory and fibroblast-derived factors found in the RA synovium drive macrophages into an unresolving novel macrophage phenotype that in part functions to feedback and support synovial fibroblast pathologic activity.


Disclosure:

L. T. Donlin,
None;

J. Ding,
None;

L. B. Ivashkiv,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/macrophage-fibroblast-crosstalk-pathways-amplify-ra-joint-pathology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology